Since IR is a hallmark of PCOS and insulin may be involved in activation of the sympathetic nervous system, insulin sensitizers may be considered to have therapeutic benefits in reducing sympathetic output in PCOS. The gene discussed is INS; the disease is polycystic ovary syndrome.